Australia's most trusted
source of pharma news
Thursday, 24 April 2025
Posted 24 April 2025 AM
The PBS could become a "brutal jungle" if US President Donald Trump decides to resurrect international price referencing, according to a new opinion piece featured in the Australian Financial Review (AFR).
Despite the temptation of higher prices for companies operating in Australia, the policy would, according to former political advisor and ex-pharma executive Vincent So, have a savage impact on medicines access.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.